FDA Inspection 1325870 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on June 30, 2026 in Channelview, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 30, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Channelview, TX (United States)